1.
Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer
by Enomoto, Yasunori
Lung cancer (Amsterdam, Netherlands), 2016, Vol.96, p.63-67

2.
New driver mutations in non-small-cell lung cancer
by Pao, William, Dr
The lancet oncology, 2011, Vol.12 (2), p.175-180

3.
The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis
by Schmidt, Eric P
Nature medicine, 2012, Vol.18 (8), p.1217-1223

4.
Altered lung structure and function in mid-childhood survivors of very preterm birth
by Simpson, Shannon J
Thorax, 2017, Vol.72 (8), p.702-711

5.
COPD, emphysema and the onset of lung cancer. A systematic review
by Mouronte-Roibás, Cecilia
Cancer letters, 2016, Vol.382 (2), p.240-244

6.
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre
by Lepri, Gemma
Annals of the rheumatic diseases, 2015, Vol.74 (1), p.124-128

7.
Left Ventricular Failure Produces Profound Lung Remodeling and Pulmonary Hypertension in Mice: Heart Failure Causes Severe Lung Disease
by Chen, Yingjie
Hypertension (Dallas, Tex. 1979), 2012, Vol.59 (6), p.1170-1178

8.
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
by Dinis-Oliveira, R. J
Critical reviews in toxicology, 2008, Vol.38 (1), p.13-71

9.
Xenogeneic cross-circulation for extracorporeal recovery of injured human lungs
by Hozain, Ahmed E
Nature medicine, 2020, Vol.26 (7), p.1102-1113

10.
Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis
by de Jong, P A
Thorax, 2006, Vol.61 (1), p.80-85

11.
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
by Ricardi, Umberto
Lung cancer (Amsterdam, Netherlands), 2009, Vol.68 (1), p.72-77

12.
Angiotensin-converting enzyme 2 protects from severe acute lung failure
by Penninger, Josef M
Nature, 2005, Vol.436 (7047), p.112-116

13.
Leisure-time vigorous physical activity is associated with better lung function: the prospective ECRHS study
by Fuertes, Elaine
Thorax, 2018, Vol.73 (4), p.376-384

14.
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation
by Horsley, Alex R
Thorax, 2013, Vol.68 (6), p.532-539

15.
A metabolomic approach to lung cancer
by Hori, Suya
Lung cancer (Amsterdam, Netherlands), 2011, Vol.74 (2), p.284-292

16.
Lung consequences in adults born prematurely
by Bolton, Charlotte E
Postgraduate medical journal, 2015, Vol.70 (6), p.574-718

17.
Lung function and cardiovascular disease: A link
by Ramalho, Sergio H.R
Trends in cardiovascular medicine, 2021, Vol.31 (2), p.93-98

18.
Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial
by Lara Edbrooke
Thorax, 2019, Vol.74 (8), p.787

19.
Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany
by Iyer, Shrividya
Lung cancer (Amsterdam, Netherlands), 2013, Vol.81 (2), p.288-293

20.
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
by Jordan, Suzana
Annals of the rheumatic diseases, 2015, Vol.74 (6), p.1188-1194
